LifeScience Biologics
Doer Biologics Initiates Phase I MAD Trial of DR10624, Receives NMPA IND Approval
The Phase I MAD study is a randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics ...
August 02, 2023 | News
Chinese Patent Granted for CytoMed Therapeutics' Allogeneic CAR-Gamma Delta T Cell Technology
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its propr...
August 02, 2023 | News
FDA Clears Terumo's Reveos® Automated Whole Blood Processing System for U.S. Commercial Use
Terumo Blood and Cell Technologies (Terumo BCT) announces U.S. Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing ...
August 02, 2023 | News
KORU Medical Systems Announces Late-Stage Endocrinological Biologic Collaboration
Under terms of the Agreement, Koru Medical will validate the Freedom Infusion System for use with the company’s drug. The drug developer is expected ...
July 31, 2023 | News
MSD and Moderna Launch Phase 3 Study for Melanoma Treatment
“As we continue our efforts to advance novel treatment options for patients with high-risk Stage IIB-IV melanoma, the initiation of the V940-001 Phas...
July 28, 2023 | News
GC Genome Enables Prognosis Prediction and Targeted Treatment in Breast Cancer
''We can gain vital insights into patient prognosis and make informed decisions regarding the most effective treatment strategies through ctDNA CNA...
July 27, 2023 | News
Hummingbird Bioscience Advances HMBD-001 Phase IB Trials in Australia, Partners with Omico for Faster Clinical Development
Hummingbird Bioscience has initiated two clinical trials in Australia evaluating HMBD-001 in patients with squamous non-small cell lung ca...
July 27, 2023 | News
HaemaLogiX, Peter MacCallum Cancer Centre Announce Myeloma CAR-T Trial Agreement
HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's ...
July 26, 2023 | News
China's Mabwell Announces NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND
B7-H3 is a member of the B7 ligand family and is overexpressed in most cancer types but expressed at a low level in normal tissues. In malignant tissues, B...
July 24, 2023 | News
SCG Cell Therapy Launches Cutting-edge Facility in Singapore for Cell Therapy Manufacturing & R&D
SCG Cell Therapy celebrates the opening of its new Cell Therapy Manufacturing Facility and R&D Centre, launching a new first-of-its-kind automatic ce...
July 20, 2023 | News
Merck and Telix Continue Collaboration for Targeted Radiation Therapy Studies.
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Com...
July 19, 2023 | News
Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND
9MW2921 is a next generation antibody-drug conjugate (ADC) developed by Mabwell based on IDDC™ (Interchain-Disulfide Drug Conjugate) platef...
July 19, 2023 | News
Duoning Biotech Acquires PreFluid to Strengthen Fluid Management Solutions
PreFluid is a leader in integrated fluid solutionsPreFluid's peristaltic pumps are widely used in medical, pharmaceutical, chemical and environmental indus...
July 19, 2023 | News
Scribe Therapeutics and Sanofi Team Up to Advance In Vivo Genetic Medicines for Sickle Cell and Genomic Disease
Predicated on the progress of the companies’ first collaboration, Sanofi has selected Scribe’s novel CRISPR by Design™ approach to driv...
July 18, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
